[HTML][HTML] German guideline for idiopathic pulmonary fibrosis–update on pharmacological therapies 2017

J Behr, A Günther, F Bonella, K Geißler… - …, 2018 - thieme-connect.com
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2–4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …

German Guideline for Idiopathic Pulmonary Fibrosis-Update on Pharmacological Therapies 2017

J Behr, A Günther, F Bonella… - Pneumologie …, 2017 - pubmed.ncbi.nlm.nih.gov
Die idiopathische Lungenfibrose (idiopathische pulmonale Fibrose, IPF) ist eine
schwerwiegende Lungenerkrankung, die häufig innerhalb von zwei bis vier Jahren nach …

German Guideline for Idiopathic Pulmonary Fibrosis–Update on Pharmacological Therapies 2017

J Behr, A Günther, F Bonella, K Geissler… - …, 2018 - epub.ub.uni-muenchen.de
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2-4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …

German guideline for idiopathic pulmonary fibrosis-update on pharmacological therapies 2017

J Behr, A Günther, F Bonella, K Geißler, D Koschel… - 2018 - publica.fraunhofer.de
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2-4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …

German Guideline for Idiopathic Pulmonary Fibrosis-Update on Pharmacological Therapies 2017

J Behr, A Günther, F Bonella, K Geißler… - Pneumologie …, 2017 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2-4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …

German Guideline for Idiopathic Pulmonary Fibrosis-Update on Pharmacological Therapies 2017

J Behr, A Günther, F Bonella… - Pneumologie …, 2018 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2-4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …

German Guideline for Idiopathic Pulmonary Fibrosis-Update on Pharmacological Therapies 2017.

J Behr, A Günther, F Bonella, K Geißler… - Pneumologie …, 2018 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2-4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …